{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:02:30Z","timestamp":1792519350388,"version":"4.5.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":69,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["66719"],"award-info":[{"award-number":["66719"]}],"id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-026-02151-5","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T05:05:14Z","timestamp":1781327114000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A systematic review and meta-analysis of fatty acid composition in polycystic ovary syndrome: perspectives from blood and follicular fluid"],"prefix":"10.1186","volume":"19","author":[{"given":"Reza","family":"Zarezadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Fattahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kobra","family":"Hamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Nouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6380-272X","authenticated-orcid":false,"given":"Masoud","family":"Darabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"issue":"9","key":"2151_CR1","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/s2213-8587(22)00163-2","volume":"10","author":"AE Joham","year":"2022","unstructured":"Joham AE, Norman RJ, Stener-Victorin E, Legro RS, Franks S, Moran LJ, Boyle J, Teede HJ. Polycystic ovary syndrome. Lancet Diabetes Endocrinol. 2022;10(9):668\u201380. https:\/\/doi.org\/10.1016\/s2213-8587(22)00163-2.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2151_CR2","doi-asserted-by":"publisher","first-page":"790454","DOI":"10.3389\/fcvm.2021.790454","volume":"8","author":"X Luo","year":"2021","unstructured":"Luo X, Cai WY, Wu XK. Prevalence, Pattern and Predictors for Dyslipidemia of Chinese Women With Polycystic Ovary Syndrome. Front Cardiovasc Med. 2021;8:790454. https:\/\/doi.org\/10.3389\/fcvm.2021.790454.","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"2151_CR3","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.fertnstert.2010.12.027","volume":"95","author":"RA Wild","year":"2011","unstructured":"Wild RA, Rizzo M, Clifton S, Carmina E. Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril. 2011;95(3):1073\u20139. https:\/\/doi.org\/10.1016\/j.fertnstert.2010.12.027. .e1-11.","journal-title":"Fertil Steril"},{"key":"2151_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jpba.2016.01.025","volume":"121","author":"YX Chen","year":"2016","unstructured":"Chen YX, Zhang XJ, Huang J, Zhou SJ, Liu F, Jiang LL, Chen M, Wan JB, Yang DZ. UHPLC\/Q-TOFMS-based plasma metabolomics of polycystic ovary syndrome patients with and without insulin resistance. J Pharm Biomed Anal. 2016;121:141\u201350. https:\/\/doi.org\/10.1016\/j.jpba.2016.01.025.","journal-title":"J Pharm Biomed Anal"},{"issue":"6","key":"2151_CR5","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1080\/00365513.2019.1658215","volume":"79","author":"CL Vonica","year":"2019","unstructured":"Vonica CL, Ilie IR, Socaciu C, Moraru C, Georgescu B, Farca\u015f A, Roman G, Mure\u015fan AA, Georgescu CE. Lipidomics biomarkers in women with polycystic ovary syndrome (PCOS) using ultra-high performance liquid chromatography-quadrupole time of flight electrospray in a positive ionization mode mass spectrometry. Scand J Clin Lab Invest. 2019;79(6):437\u201342. https:\/\/doi.org\/10.1080\/00365513.2019.1658215.","journal-title":"Scand J Clin Lab Invest"},{"issue":"1","key":"2151_CR6","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12920-021-01058-y","volume":"14","author":"Y Yu","year":"2021","unstructured":"Yu Y, Tan P, Zhuang Z, Wang Z, Zhu L, Qiu R, Xu H. Untargeted metabolomic approach to study the serum metabolites in women with polycystic ovary syndrome. BMC Med Genomics. 2021;14(1):206. https:\/\/doi.org\/10.1186\/s12920-021-01058-y.","journal-title":"BMC Med Genomics"},{"issue":"1","key":"2151_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12958-019-0490-y","volume":"17","author":"Z Sun","year":"2019","unstructured":"Sun Z, Chang HM, Wang A, Song J, Zhang X, Guo J, Leung PCK, Lian F. Identification of potential metabolic biomarkers of polycystic ovary syndrome in follicular fluid by SWATH mass spectrometry. Reprod Biol Endocrinol. 2019;17(1):45. https:\/\/doi.org\/10.1186\/s12958-019-0490-y.","journal-title":"Reprod Biol Endocrinol"},{"key":"2151_CR8","doi-asserted-by":"publisher","first-page":"1414289","DOI":"10.3389\/fendo.2024.1414289","volume":"15","author":"M Zhang","year":"2024","unstructured":"Zhang M, Wang Y, Di J, Zhang X, Liu Y, Zhang Y, Li B, Qi S, Cao X, Liu L, Liu S, Xu F. High coverage of targeted lipidomics revealed lipid changes in the follicular fluid of patients with insulin-resistant polycystic ovary syndrome and a positive correlation between plasmalogens and oocyte quality. Front Endocrinol (Lausanne). 2024;15:1414289. https:\/\/doi.org\/10.3389\/fendo.2024.1414289.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2151_CR9","doi-asserted-by":"publisher","first-page":"R15","DOI":"10.1530\/rep-13-0251","volume":"148","author":"KR Dunning","year":"2014","unstructured":"Dunning KR, Russell DL, Robker RL. Lipids and oocyte developmental competence: the role of fatty acids and \u03b2-oxidation. Reproduction. 2014;148(1):R15\u201327. https:\/\/doi.org\/10.1530\/rep-13-0251.","journal-title":"Reproduction"},{"key":"2151_CR10","doi-asserted-by":"publisher","unstructured":"Czumaj A, \u015aledzi\u0144ski T, Carrero JJ, Stepnowski P, Sikorska-Wisniewska M, Chmielewski M, Mika A. Alterations of Fatty Acid Profile May Contribute to Dyslipidemia in Chronic Kidney Disease by Influencing Hepatocyte Metabolism. Int J Mol Sci. 2019;20(10). https:\/\/doi.org\/10.3390\/ijms20102470.","DOI":"10.3390\/ijms20102470"},{"issue":"1","key":"2151_CR11","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/jdi.13924","volume":"14","author":"N Taya","year":"2023","unstructured":"Taya N, Katakami N, Omori K, Hosoe S, Watanabe H, Takahara M, Miyashita K, Nishizawa H, Konya Y, Obara S, Hidaka A, Nakao M, Takahashi M, Izumi Y, Shimomura I, Bamba T. Change in fatty acid composition of plasma triglyceride caused by a 2 week comprehensive risk management for diabetes: A prospective observational study of type 2 diabetes patients with supercritical fluid chromatography\/mass spectrometry-based semi-target lipidomic analysis. J Diabetes Investig. 2023;14(1):102\u201310. https:\/\/doi.org\/10.1111\/jdi.13924.","journal-title":"J Diabetes Investig"},{"issue":"5","key":"2151_CR12","doi-asserted-by":"publisher","first-page":"E707","DOI":"10.1152\/ajpendo.00532.2018","volume":"316","author":"M Cree-Green","year":"2019","unstructured":"Cree-Green M, Carreau AM, Rahat H, Garcia-Reyes Y, Bergman BC, Pyle L, Nadeau KJ. Amino acid and fatty acid metabolomic profile during fasting and hyperinsulinemia in girls with polycystic ovarian syndrome. Am J Physiol Endocrinol Metab. 2019;316(5):E707\u201318. https:\/\/doi.org\/10.1152\/ajpendo.00532.2018.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2151_CR13","doi-asserted-by":"publisher","first-page":"104462","DOI":"10.1016\/j.phrs.2019.104462","volume":"149","author":"J Heshmati","year":"2019","unstructured":"Heshmati J, Morvaridzadeh M, Maroufizadeh S, Akbari A, Yavari M, Amirinejad A, Maleki-Hajiagha A, Sepidarkish M. Omega-3 fatty acids supplementation and oxidative stress parameters: A systematic review and meta-analysis of clinical trials. Pharmacol Res. 2019;149:104462. https:\/\/doi.org\/10.1016\/j.phrs.2019.104462.","journal-title":"Pharmacol Res"},{"key":"2151_CR14","doi-asserted-by":"publisher","first-page":"175628482513148","DOI":"10.1177\/17562848251314827","volume":"18","author":"N Haskey","year":"2025","unstructured":"Haskey N, Letef C, Sousa JA, Yousuf M, Taylor LM, McKay DM, Ma C, Ghosh S, Gibson DL, Raman M. Exploring the connection between erythrocyte membrane fatty acid composition and oxidative stress in patients undergoing the Crohn\u2019s disease Therapeutic Diet Intervention (CD-TDI). Th Adv Gastroenterol. 2025;18:17562848251314827. https:\/\/doi.org\/10.1177\/17562848251314827.","journal-title":"Th Adv Gastroenterol"},{"key":"2151_CR15","doi-asserted-by":"publisher","unstructured":"Clarke ED, Stanford J, Ferguson JJA, Wood LG, Collins CE. Red Blood Cell Membrane Fatty Acid Composition, Dietary Fatty Acid Intake and Diet Quality as Predictors of Inflammation in a Group of Australian Adults. Nutrients. 2023;15(10). https:\/\/doi.org\/10.3390\/nu15102405.","DOI":"10.3390\/nu15102405"},{"issue":"9","key":"2151_CR16","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.1016\/j.tjnut.2024.07.015","volume":"154","author":"R Virk","year":"2024","unstructured":"Virk R, Cook K, Cavazos A, Wassall SR, Gowdy KM, Shaikh SR. How Membrane Phospholipids Containing Long-Chain Polyunsaturated Fatty Acids and Their Oxidation Products Orchestrate Lipid Raft Dynamics to Control Inflammation. J Nutr. 2024;154(9):2862\u201370. https:\/\/doi.org\/10.1016\/j.tjnut.2024.07.015.","journal-title":"J Nutr"},{"issue":"2","key":"2151_CR17","doi-asserted-by":"publisher","first-page":"127","DOI":"10.22074\/ijfs.2022.551310.1284","volume":"17","author":"N Emami","year":"2023","unstructured":"Emami N, Moini A, Bakhtiarizadeh MR, Yaghmaei P, Shahhoseini M, Alizadeh A. Fatty Acids in Subcutaneous Adipose Tissue of Pregnant Women with and without Polycystic Ovary Syndrome Are Associated with Genes Related to Steroidogenesis: A Case-Control Study. Int J Fertil Steril. 2023;17(2):127\u201332. https:\/\/doi.org\/10.22074\/ijfs.2022.551310.1284.","journal-title":"Int J Fertil Steril"},{"issue":"2","key":"2151_CR18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.22074\/ijfs.2015.4240","volume":"9","author":"M Zaree","year":"2015","unstructured":"Zaree M, Shahnazi V, Fayezi S, Darabi M, Mehrzad-Sadaghiani M, Darabi M, Khani S, Nouri M. Expression Levels of PPAR\u03b3 and CYP-19 in Polycystic Ovarian Syndrome Primary Granulosa Cells: Influence of \u03c9-3 Fatty Acid. Int J Fertil Steril. 2015;9(2):197\u2013204. https:\/\/doi.org\/10.22074\/ijfs.2015.4240.","journal-title":"Int J Fertil Steril"},{"issue":"5","key":"2151_CR19","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s10815-022-02462-8","volume":"39","author":"Z Zhao","year":"2022","unstructured":"Zhao Z, Fan Q, Zhu Q, He R, Li Y, Liu C, Wang J, Liang X. Decreased fatty acids induced granulosa cell apoptosis in patients with diminished ovarian reserve. J Assist Reprod Genet. 2022;39(5):1105\u201314. https:\/\/doi.org\/10.1007\/s10815-022-02462-8.","journal-title":"J Assist Reprod Genet"},{"key":"2151_CR20","doi-asserted-by":"publisher","first-page":"112317","DOI":"10.1016\/j.mce.2024.112317","volume":"592","author":"S Fayezi","year":"2024","unstructured":"Fayezi S, Oehms S, Wolff H, von Gudenberg M, Ponnaiah M, Lhomme T, Strowitzki A, Germeyer. De novo synthesis of monounsaturated fatty acids modulates exosome-mediated lipid export from human granulosa cells. Mol Cell Endocrinol. 2024;592:112317. https:\/\/doi.org\/10.1016\/j.mce.2024.112317.","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"2151_CR21","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.rbmo.2020.09.024","volume":"42","author":"R Zarezadeh","year":"2021","unstructured":"Zarezadeh R, Nouri M, Hamdi K, Shaaker M, Mehdizadeh A, Darabi M. Fatty acids of follicular fluid phospholipids and triglycerides display distinct association with IVF outcomes. Reprod Biomed Online. 2021;42(2):301\u20139. https:\/\/doi.org\/10.1016\/j.rbmo.2020.09.024.","journal-title":"Reprod Biomed Online"},{"key":"2151_CR22","doi-asserted-by":"publisher","first-page":"112616","DOI":"10.1016\/j.nut.2024.112616","volume":"130","author":"V De Cosmi","year":"2025","unstructured":"De Cosmi V, Cipriani S, Syren ML, Turolo S, Parazzini F, Reschini M, Abodi M, Vegetti W, Chiaffarino F, Bertoni C, Somigliana E, Agostoni C. Peripheral fatty acids and outcome of assisted reproduction. Nutrition. 2025;130:112616. https:\/\/doi.org\/10.1016\/j.nut.2024.112616.","journal-title":"Nutrition"},{"issue":"1","key":"2151_CR23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12958-022-00974-7","volume":"20","author":"Y Liu","year":"2022","unstructured":"Liu Y, Tilleman K, Vlaeminck B, Gervais R, Chouinard PY, De Sutter P, Fievez V. The fatty acid composition in follicles is related to the developmental potential of oocytes up to the blastocyst stage: a single-centre cohort study. Reprod Biol Endocrinol. 2022;20(1):107. https:\/\/doi.org\/10.1186\/s12958-022-00974-7.","journal-title":"Reprod Biol Endocrinol"},{"key":"2151_CR24","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"2151_CR25","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, Carpenter JR, Chan AW, Churchill R, Deeks JJ, Hr\u00f3bjartsson A, Kirkham J, J\u00fcni P, Loke YK, Pigott TD, Ramsay CR, Regidor D, Rothstein HR, Sandhu L, Santaguida PL, Sch\u00fcnemann HJ, Shea B, Shrier I, Tugwell P, Turner L, Valentine JC, Waddington H, Waters E, Wells GA, Whiting PF, Higgins JP. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. https:\/\/doi.org\/10.1136\/bmj.i4919.","journal-title":"BMJ"},{"issue":"1","key":"2151_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jrsm.1411","volume":"12","author":"LA McGuinness","year":"2021","unstructured":"McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods. 2021;12(1):55\u201361. https:\/\/doi.org\/10.1002\/jrsm.1411.","journal-title":"Res Synth Methods"},{"key":"2151_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2288-5-13","volume":"5","author":"SP Hozo","year":"2005","unstructured":"Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13. https:\/\/doi.org\/10.1186\/1471-2288-5-13.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"2151_CR28","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1017\/s0007114521003007","volume":"128","author":"L Lu","year":"2022","unstructured":"Lu L, Li X, Lv L, Xu Y, Wu B, Huang C. Dietary and serum n-3 PUFA and polycystic ovary syndrome: a matched case-control study. Br J Nutr. 2022;128(1):114\u201323. https:\/\/doi.org\/10.1017\/s0007114521003007.","journal-title":"Br J Nutr"},{"key":"2151_CR29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.plefa.2017.09.001","volume":"126","author":"M Szczuko","year":"2017","unstructured":"Szczuko M, Zapa\u0142owska-Chwy\u0107 M, Drozd A, Maciejewska D, Starczewski A, Stachowska E. Metabolic pathways of oleic and palmitic acid are intensified in PCOS patients with normal androgen levels. Prostaglandins Leukot Essent Fat Acids. 2017;126:105\u201311. https:\/\/doi.org\/10.1016\/j.plefa.2017.09.001.","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"key":"2151_CR30","doi-asserted-by":"publisher","first-page":"1077590","DOI":"10.3389\/fendo.2023.1077590","volume":"14","author":"Y Tian","year":"2023","unstructured":"Tian Y, Zhang J, Li M, Shang J, Bai X, Zhang H, Wang Y, Chen H, Song X. Serum fatty acid profiles associated with metabolic risk in women with polycystic ovary syndrome. Front Endocrinol (Lausanne). 2023;14:1077590. https:\/\/doi.org\/10.3389\/fendo.2023.1077590.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"2151_CR31","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1093\/humrep\/deu281","volume":"29","author":"GR Willis","year":"2014","unstructured":"Willis GR, Connolly K, Ladell K, Davies TS, Guschina IA, Ramji D, Miners K, Price DA, Clayton A, James PE, Rees DA. Young women with polycystic ovary syndrome have raised levels of circulating annexin V-positive platelet microparticles. Hum Reprod. 2014;29(12):2756\u201363. https:\/\/doi.org\/10.1093\/humrep\/deu281.","journal-title":"Hum Reprod"},{"key":"2151_CR32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jpba.2014.02.014","volume":"95","author":"XJ Zhang","year":"2014","unstructured":"Zhang XJ, Huang LL, Su H, Chen YX, Huang J, He C, Li P, Yang DZ, Wan JB. Characterizing plasma phospholipid fatty acid profiles of polycystic ovary syndrome patients with and without insulin resistance using GC-MS and chemometrics approach. J Pharm Biomed Anal. 2014;95:85\u201392. https:\/\/doi.org\/10.1016\/j.jpba.2014.02.014.","journal-title":"J Pharm Biomed Anal"},{"issue":"3","key":"2151_CR33","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1210\/jc.2016-2692","volume":"102","author":"S Li","year":"2017","unstructured":"Li S, Chu Q, Ma J, Sun Y, Tao T, Huang R, Liao Y, Yue J, Zheng J, Wang L, Xue X, Zhu M, Kang X, Yin H, Liu W. Discovery of Novel Lipid Profiles in PCOS: Do Insulin and Androgen Oppositely Regulate Bioactive Lipid Production? J Clin Endocrinol Metab. 2017;102(3):810\u201321. https:\/\/doi.org\/10.1210\/jc.2016-2692.","journal-title":"J Clin Endocrinol Metab"},{"key":"2151_CR34","doi-asserted-by":"publisher","unstructured":"Regidor PA, de la Rosa X, M\u00fcller A, Mayr M, Gonzalez Santos F, Gracia Banzo R, Rizo JM. PCOS: A Chronic Disease That Fails to Produce Adequately Specialized Pro-Resolving Lipid Mediators (SPMs). Biomedicines. 2022;10(2). https:\/\/doi.org\/10.3390\/biomedicines10020456.","DOI":"10.3390\/biomedicines10020456"},{"key":"2151_CR35","doi-asserted-by":"publisher","unstructured":"Ma Y, Zheng L, Wang Y, Gao Y, Xu Y. Arachidonic Acid in Follicular Fluid of PCOS Induces Oxidative Stress in a Human Ovarian Granulosa Tumor Cell Line (KGN) and Upregulates GDF15 Expression as a Response. Front Endocrinol (Lausanne). 2022;13. https:\/\/doi.org\/10.3389\/fendo.2022.865748.","DOI":"10.3389\/fendo.2022.865748"},{"issue":"1","key":"2151_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/rep-22-0023","volume":"164","author":"Y Feng","year":"2022","unstructured":"Feng Y, Qi J, Xue X, Li X, Liao Y, Sun Y, Tao Y, Yin H, Liu W, Li S, Huang R. Follicular free fatty acid metabolic signatures and their effects on oocyte competence in non-obese PCOS patients. Reproduction. 2022;164(1):1\u20138. https:\/\/doi.org\/10.1530\/rep-22-0023.","journal-title":"Reproduction"},{"issue":"8","key":"2151_CR37","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1210\/clinem\/dgac281","volume":"107","author":"Y Lai","year":"2022","unstructured":"Lai Y, Ye Z, Mu L, Zhang Y, Long X, Zhang C, Li R, Zhao Y, Qiao J. Elevated Levels of Follicular Fatty Acids Induce Ovarian Inflammation via ERK1\/2 and Inflammasome Activation in PCOS. J Clin Endocrinol Metab. 2022;107(8):2307\u201317. https:\/\/doi.org\/10.1210\/clinem\/dgac281.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2151_CR38","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1530\/rep-19-0136","volume":"159","author":"S Li","year":"2020","unstructured":"Li S, Qi J, Tao Y, Zhu Q, Huang R, Liao Y, Yue J, Liu W, Zhao H, Yin H, Sun Y. Elevated levels of arachidonic acid metabolites in follicular fluid of PCOS patients. Reproduction. 2020;159(2):159\u201369. https:\/\/doi.org\/10.1530\/rep-19-0136.","journal-title":"Reproduction"},{"issue":"11","key":"2151_CR39","doi-asserted-by":"publisher","first-page":"E2269","DOI":"10.1210\/jc.2013-3942","volume":"99","author":"Z Niu","year":"2014","unstructured":"Niu Z, Lin N, Gu R, Sun Y, Feng Y. Associations between insulin resistance, free fatty acids, and oocyte quality in polycystic ovary syndrome during in vitro fertilization. J Clin Endocrinol Metab. 2014;99(11):E2269\u201376. https:\/\/doi.org\/10.1210\/jc.2013-3942.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2151_CR40","doi-asserted-by":"publisher","first-page":"100765","DOI":"10.1016\/j.jlr.2025.100765","volume":"66","author":"GI Lancaster","year":"2025","unstructured":"Lancaster GI, Murphy AJ. Do physiological changes in fatty acid composition alter cellular ferroptosis susceptibility and influence cell function? J Lipid Res. 2025;66(4):100765. https:\/\/doi.org\/10.1016\/j.jlr.2025.100765.","journal-title":"J Lipid Res"},{"key":"2151_CR41","doi-asserted-by":"publisher","unstructured":"Chaaba R, Bouaziz A, Ben Amor A, Mnif W, Hammami M, Mehri S. Fatty Acid Profile and Genetic Variants of Proteins Involved in Fatty Acid Metabolism Could Be Considered as Disease Predictor. Diagnostics (Basel). 2023;13(5). https:\/\/doi.org\/10.3390\/diagnostics13050979.","DOI":"10.3390\/diagnostics13050979"},{"issue":"10","key":"2151_CR42","doi-asserted-by":"publisher","first-page":"e74927","DOI":"10.1371\/journal.pone.0074927","volume":"8","author":"C Hellmuth","year":"2013","unstructured":"Hellmuth C, Demmelmair H, Schmitt I, Peissner W, Bl\u00fcher M, Koletzko B. Association between plasma nonesterified fatty acids species and adipose tissue fatty acid composition. PLoS ONE. 2013;8(10):e74927. https:\/\/doi.org\/10.1371\/journal.pone.0074927.","journal-title":"PLoS ONE"},{"issue":"1","key":"2151_CR43","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1210\/jc.2006-1665","volume":"92","author":"M Cort\u00f3n","year":"2007","unstructured":"Cort\u00f3n M, Botella-Carretero JI, Bengur\u00eda A, Villuendas G, Zaballos A, San Mill\u00e1n JL, Escobar-Morreale HF, Peral B. Differential gene expression profile in omental adipose tissue in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2007;92(1):328\u201337. https:\/\/doi.org\/10.1210\/jc.2006-1665.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2151_CR44","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s13148-020-00970-x","volume":"12","author":"KL Leung","year":"2020","unstructured":"Leung KL, Sanchita S, Pham CT, Davis BA, Okhovat M, Ding X, Dumesic P, Grogan TR, Williams KJ, Morselli M, Ma F, Carbone L, Li X, Pellegrini M, Dumesic DA, Chazenbalk GD. Dynamic changes in chromatin accessibility, altered adipogenic gene expression, and total versus de novo fatty acid synthesis in subcutaneous adipose stem cells of normal-weight polycystic ovary syndrome (PCOS) women during adipogenesis: evidence of cellular programming. Clin Epigenetics. 2020;12(1):181. https:\/\/doi.org\/10.1186\/s13148-020-00970-x.","journal-title":"Clin Epigenetics"},{"issue":"1","key":"2151_CR45","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1080\/21623945.2019.1710021","volume":"9","author":"N Emami","year":"2020","unstructured":"Emami N, Alizadeh A, Moini A, Yaghmaei P, Shahhosseini M. Differences in fatty acid profiles and desaturation indices of abdominal subcutaneous adipose tissue between pregnant women with and without PCOS. Adipocyte. 2020;9(1):16\u201323. https:\/\/doi.org\/10.1080\/21623945.2019.1710021.","journal-title":"Adipocyte"},{"issue":"16","key":"2151_CR46","doi-asserted-by":"publisher","first-page":"4683","DOI":"10.1007\/s00216-015-8670-x","volume":"407","author":"F Dong","year":"2015","unstructured":"Dong F, Deng D, Chen H, Cheng W, Li Q, Luo R, Ding S. Serum metabolomics study of polycystic ovary syndrome based on UPLC-QTOF-MS coupled with a pattern recognition approach. Anal Bioanal Chem. 2015;407(16):4683\u201395. https:\/\/doi.org\/10.1007\/s00216-015-8670-x.","journal-title":"Anal Bioanal Chem"},{"key":"2151_CR47","doi-asserted-by":"publisher","first-page":"109548","DOI":"10.1016\/j.jnutbio.2023.109548","volume":"125","author":"Y Xu","year":"2024","unstructured":"Xu Y, Zhou Z, Zhang G, Yang Z, Shi Y, Jiang Z, Liu Y, Chen H, Huang H, Zhang Y, Pan J. Metabolome implies increased fatty acid utilization and histone methylation in the follicles from hyperandrogenic PCOS women. J Nutr Biochem. 2024;125:109548. https:\/\/doi.org\/10.1016\/j.jnutbio.2023.109548.","journal-title":"J Nutr Biochem"},{"key":"2151_CR48","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.cca.2022.11.033","volume":"538","author":"Y Sun","year":"2023","unstructured":"Sun Y, Hao L, Han W, Luo J, Zheng J, Yuan D, Ye H, Li Q, Huang G, Han T, Yang Z. Intrafollicular fluid metabolic abnormalities in relation to ovarian hyperstimulation syndrome: Follicular fluid metabolomics via gas chromatography-mass spectrometry. Clin Chim Acta. 2023;538:189\u2013202. https:\/\/doi.org\/10.1016\/j.cca.2022.11.033.","journal-title":"Clin Chim Acta"},{"issue":"2","key":"2151_CR49","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/jcp.27101","volume":"234","author":"R Zarezadeh","year":"2019","unstructured":"Zarezadeh R, Mehdizadeh A, Leroy J, Nouri M, Fayezi S, Darabi M. Action mechanisms of n-3 polyunsaturated fatty acids on the oocyte maturation and developmental competence: Potential advantages and disadvantages. J Cell Physiol. 2019;234(2):1016\u201329. https:\/\/doi.org\/10.1002\/jcp.27101.","journal-title":"J Cell Physiol"},{"issue":"6","key":"2151_CR50","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1373\/clinchem.2011.176396","volume":"58","author":"HF Escobar-Morreale","year":"2012","unstructured":"Escobar-Morreale HF, Samino S, Insenser M, Vinaixa M, Luque-Ram\u00edrez M, Lasunci\u00f3n MA, Correig X. Metabolic heterogeneity in polycystic ovary syndrome is determined by obesity: plasma metabolomic approach using GC-MS. Clin Chem. 2012;58(6):999\u20131009. https:\/\/doi.org\/10.1373\/clinchem.2011.176396.","journal-title":"Clin Chem"},{"key":"2151_CR51","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1741-7015-10-153","volume":"10","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Fu L, Li R, Wang LN, Yang Y, Liu NN, Zhang CM, Wang Y, Liu P, Tu BB, Zhang X, Qiao J. Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis. BMC Med. 2012;10:153. https:\/\/doi.org\/10.1186\/1741-7015-10-153.","journal-title":"BMC Med"},{"key":"2151_CR52","doi-asserted-by":"publisher","first-page":"638727","DOI":"10.3389\/fendo.2021.638727","volume":"12","author":"I Diboun","year":"2021","unstructured":"Diboun I, Ramanjaneya M, Ahmed L, Bashir M, Butler AE, Albagha O, Abou-Samra AB, Atkin SL, Mazloum NA, Elrayess MA. Metabolomic Profiling of Pregnancies With Polycystic Ovary Syndrome Identifies a Unique Metabolic Signature and Potential Predictive Biomarkers of Low Birth Weight. Front Endocrinol (Lausanne). 2021;12:638727. https:\/\/doi.org\/10.3389\/fendo.2021.638727.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2151_CR53","doi-asserted-by":"publisher","first-page":"e18194","DOI":"10.7717\/peerj.18194","volume":"12","author":"Y Xuan","year":"2024","unstructured":"Xuan Y, Hong X, Zhou X, Yan T, Qin P, Peng D, Wang B. The vaginal metabolomics profile with features of polycystic ovary syndrome: a pilot investigation in China. PeerJ. 2024;12:e18194. https:\/\/doi.org\/10.7717\/peerj.18194.","journal-title":"PeerJ"},{"issue":"3","key":"2151_CR54","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3945\/ajcn.110.005538","volume":"93","author":"N Phelan","year":"2011","unstructured":"Phelan N, O\u2019Connor A, Kyaw Tun T, Correia N, Boran G, Roche HM, Gibney J. Hormonal and metabolic effects of polyunsaturated fatty acids in young women with polycystic ovary syndrome: results from a cross-sectional analysis and a randomized, placebo-controlled, crossover trial. Am J Clin Nutr. 2011;93(3):652\u201362. https:\/\/doi.org\/10.3945\/ajcn.110.005538.","journal-title":"Am J Clin Nutr"},{"issue":"7","key":"2151_CR55","doi-asserted-by":"publisher","first-page":"e70518","DOI":"10.1096\/fj.202402648RR","volume":"39","author":"W Zhang","year":"2025","unstructured":"Zhang W, Wu F. Elevated Linoleic Acid Intake Becomes a Risk Factor for Polycystic Ovary Syndrome by Affecting Ovarian Granulosa Cells. Faseb j. 2025;39(7):e70518. https:\/\/doi.org\/10.1096\/fj.202402648RR.","journal-title":"Faseb j"},{"key":"2151_CR56","doi-asserted-by":"publisher","first-page":"960274","DOI":"10.3389\/fendo.2022.960274","volume":"13","author":"Y Ding","year":"2022","unstructured":"Ding Y, Jiang Y, Zhu M, Zhu Q, He Y, Lu Y, Wang Y, Qi J, Feng Y, Huang R, Yin H, Li S, Sun Y. Follicular fluid lipidomic profiling reveals potential biomarkers of polycystic ovary syndrome: A pilot study. Front Endocrinol (Lausanne). 2022;13:960274. https:\/\/doi.org\/10.3389\/fendo.2022.960274.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"2151_CR57","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1111\/jcmm.13614","volume":"22","author":"R Huang","year":"2018","unstructured":"Huang R, Xue X, Li S, Wang Y, Sun Y, Liu W, Yin H, Tao T. Alterations of polyunsaturated fatty acid metabolism in ovarian tissues of polycystic ovary syndrome rats. J Cell Mol Med. 2018;22(7):3388\u201396. https:\/\/doi.org\/10.1111\/jcmm.13614.","journal-title":"J Cell Mol Med"},{"key":"2151_CR58","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.plefa.2017.01.009","volume":"117","author":"S Gellert","year":"2017","unstructured":"Gellert S, Schuchardt JP, Hahn A. Low long chain omega-3 fatty acid status in middle-aged women. Prostaglandins Leukot Essent Fat Acids. 2017;117:54\u20139. https:\/\/doi.org\/10.1016\/j.plefa.2017.01.009.","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"issue":"1","key":"2151_CR59","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1017\/s0029665124000181","volume":"84","author":"WL Hall","year":"2025","unstructured":"Hall WL. Long chain n-3 polyunsaturated fatty acid intake across the life span for cardiovascular disease prevention in women. Proc Nutr Soc. 2025;84(1):98\u2013109. https:\/\/doi.org\/10.1017\/s0029665124000181.","journal-title":"Proc Nutr Soc"},{"key":"2151_CR60","doi-asserted-by":"publisher","unstructured":"Mousa A, Huynh K, Ellery SJ, Strauss BJ, Joham AE, de Courten B, Meikle PJ, Teede HJ. Novel Lipidomic Signature Associated With Metabolic Risk in Women With and Without Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2022;107(5):e1987-e1999. https:\/\/doi.org\/10.1210\/clinem\/dgab931","DOI":"10.1210\/clinem\/dgab931"},{"key":"2151_CR61","doi-asserted-by":"publisher","first-page":"1016943","DOI":"10.3389\/fnut.2022.1016943","volume":"9","author":"L Lu","year":"2022","unstructured":"Lu L, Li X, Lv L, Xu Y, Wu B, Huang C. Associations between omega-3 fatty acids and insulin resistance and body composition in women with polycystic ovary syndrome. Front Nutr. 2022;9:1016943. https:\/\/doi.org\/10.3389\/fnut.2022.1016943.","journal-title":"Front Nutr"},{"issue":"12","key":"2151_CR62","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1080\/09513590.2022.2148647","volume":"38","author":"M Li","year":"2022","unstructured":"Li M, Tian Y, Lv Y, Xu Y, Bai X, Zhang H, Wang Y, Song X. The association between serum fatty acids and pregnancy in PCOS women undergoing ovulation induction. Gynecol Endocrinol. 2022;38(12):1097\u2013103. https:\/\/doi.org\/10.1080\/09513590.2022.2148647.","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"2151_CR63","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12958-018-0346-x","volume":"16","author":"K Yang","year":"2018","unstructured":"Yang K, Zeng L, Bao T, Ge J. Effectiveness of Omega-3 fatty acid for polycystic ovary syndrome: a systematic review and meta-analysis. Reprod Biol Endocrinol. 2018;16(1):27. https:\/\/doi.org\/10.1186\/s12958-018-0346-x.","journal-title":"Reprod Biol Endocrinol"},{"issue":"6","key":"2151_CR64","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1017\/s0007114520003207","volume":"125","author":"JAG Tosatti","year":"2021","unstructured":"Tosatti JAG, Alves MT, C\u00e2ndido AL, Reis FM, Ara\u00fajo VE, Gomes KB. Influence of n-3 fatty acid supplementation on inflammatory and oxidative stress markers in patients with polycystic ovary syndrome: a systematic review and meta-analysis. Br J Nutr. 2021;125(6):657\u201368. https:\/\/doi.org\/10.1017\/s0007114520003207.","journal-title":"Br J Nutr"},{"issue":"1","key":"2151_CR65","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13048-023-01130-4","volume":"16","author":"J Zhou","year":"2023","unstructured":"Zhou J, Zuo W, Tan Y, Wang X, Zhu M, Zhang H. Effects of n-3 polyunsaturated fatty acid on metabolic status in women with polycystic ovary syndrome: a meta-analysis of randomized controlled trials. J Ovarian Res. 2023;16(1):54. https:\/\/doi.org\/10.1186\/s13048-023-01130-4.","journal-title":"J Ovarian Res"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-026-02151-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02151-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02151-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:03:59Z","timestamp":1787310239000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13048-026-02151-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2151"],"URL":"https:\/\/doi.org\/10.1186\/s13048-026-02151-5","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"264"}}